pretickt

Is DOC a good stock to buy?

Healthpeak Properties, Inc. · end-of-day data as of Nov 13, 2026

Healthpeak
DOC · $13.78B
$19.98-0.2%
Nov 13, 2026 · close
$20SepOctNov9:3016:003 months -0.7%Nov 13 · close
▲ 5
  • PT$21.45 +7.4%
  • ConsensusBuy · 23
  • P/E vs own-51.8%
  • MAs3 of 4
  • MACD0.12
Neutral
  • Earnings in80d
  • P/E38.4x
  • RSI56
  • Support-3.2%
  • Resistance+0.9%
  • Off 52w high-12.9%
  • Volume0.8x
  • Bollingerupper half
  • News0.00
  • FCF yield+0.1%
  • Trendsideways
  • Sector→ -1.7%
  • 52w range$16–$23
  • ATR+2.4%
  • Off ATH-64.4%
  • MA20×50↑ in ~2d
▼ 2
  • P/E vs sector+25.7%
  • Insiders-$127K

Updates with the 15-min delayed price. Not a forecast or investment advice.

Is Healthpeak a good stock to buy?

Healthpeak is strong on 1 of the 4 questions about the business; weak on economics. The price is low: 38.4 times its earnings, below its 3-year median of 51.5 (Nov 13, 2026). pretickt does not say whether to buy or sell.

  1. Demand growing
  2. Advantage some edge
  3. Economics profits falling
  4. Execution no reading
  5. Fragility some risks
  6. Price below its usual
DemandDo people want more of what it sells?growing

DOC sales growth revenue growth

+11%a year, for the last 3 years

Healthpeak's sales grew 11% a year for 3 years, to $2.82B in fiscal 2025.

DOC analysts' forecast revenue estimates

+7%the sales they expect next fiscal year, on the last

Analysts expect Healthpeak's sales to grow 7% to $3.01B in fiscal 2026 (3 analysts).

DOC peers

pretickt analysis-20%its sales in 12 months, on a year before

Healthpeak's sales fell 20% in the 12 months to Sep 30, 2026; Welltower's grew 40%, Ventas' grew 22%, Regency Centers' grew 12% and Mid-America Apartment Communities' grew 1%.

DOC sales by business revenue by segment

47%of its sales from Outpatient Medical Buildings

Outpatient Medical Buildings brought Healthpeak 47% of its sales in fiscal 2025; Lab 31%.

Advantage moatIs it hard to copy?some edge

DOC margin on each sale gross margin

-15%left after making the product

Healthpeak kept -15% of each sale after making the product in the 12 months to Sep 30, 2026; its peers' median is 42%.

EconomicsDoes it make good money?profits falling

DOC profit per share

-72%in its last fiscal year

Healthpeak's earnings per share fell 72% in fiscal 2025, to $0.10.

ExecutionDoes it deliver what it promises?no reading

DOC insider selling

-$341Ksold, net, by its executives in 12 months

Healthpeak's executives and directors sold a net $341K of shares in the 12 months to Nov 13, 2026; none bought.

DOC number of employees

+6%more people in a year

Healthpeak had 411 employees at the end of fiscal 2025, 6% more than a year before.

DOC CEO pay

$10.07Mfor fiscal 2025, 72% of it in stock and options

Healthpeak paid its CEO $10.07M for fiscal 2025, 72% of it in stock and options.

Fragility risksCould something break it?some risks

DOC financial health Altman Z-score

0.4Altman Z-score, safe above 3

Healthpeak's Altman Z-score is 0.4 (Nov 13, 2026), below 1.8, the distress zone.

DOC biggest customers

under 10%of sales from any one customer

No customer made 10% of Healthpeak's sales in fiscal 2025.

Price valuationIs the price reasonable?below its usual

DOC price vs profit P/E ratio

38.4×a year's earnings

Healthpeak's P/E ratio is 38.4 (Nov 13, 2026), below its 3-year median of 51.5.

DOC price vs peers

pretickt analysis38.4×a year's earnings, against its peers

Investors pay 38.4 times Healthpeak's earnings (Nov 13, 2026), more than for Mid-America Apartment Communities (35.7) and Regency Centers (25.8), less than for Ventas (167.8) and Welltower (120.4).

DOC analysts' target price target

+7%to their average target

Analysts' average price target for Healthpeak is $21.45, 7% above the Nov 13, 2026 close of $19.98.

What is Healthpeak's P/E ratio?

Healthpeak's P/E ratio is 38.4 (Nov 13, 2026), below its 3-year median of 51.5. Investors pay 38.4 times Healthpeak's earnings (Nov 13, 2026), more than for Mid-America Apartment Communities (35.7) and Regency Centers (25.8), less than for Ventas (167.8) and Welltower (120.4).

Are insiders selling Healthpeak stock?

Healthpeak's executives and directors sold a net $341K of shares in the 12 months to Nov 13, 2026; none bought.

How does Healthpeak make money?

Outpatient Medical Buildings brought Healthpeak 47% of its sales in fiscal 2025; Lab 31%.

How many employees does Healthpeak have?

Healthpeak had 411 employees at the end of fiscal 2025, 6% more than a year before.

Who are Healthpeak's biggest customers?

No customer made 10% of Healthpeak's sales in fiscal 2025.

From the companies' statements (FMP), their filings read by pretickt, the analysts and the insiders, as of Nov 13, 2026. Each card says what a fact means for its question, never what to do with the stock: for information only, not investment advice.